Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Protekai

Protekai
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$100K LATEST DEAL AMOUNT
2 INVESTORS
Description

Operator of a biotechnology research agency intended to be used for the development of protein-based drugs. The company's biotechnology research agency is working with a de novo fluorescent protein extracted from the marine organism Physalia, enabling clients to avail a new class of near-infrared fluorescent proteins, opening the door to a myriad of diagnostic & research applications

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • HI
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Protekai’s full profile, request a free trial.

Protekai Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 07-Dec-2010 $100K 00000 00000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Protekai Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Seed 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
To view this company’s complete Cap Table, request access »

Protekai Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
University of Hawaii Foundation Limited Partner Minority 000 0000 000000 0
HiBEAM Accelerator/Incubator Minority 000 0000 000000 0

Protekai Executive Team (1)

Name Title Board
Seat
Contact
Info
Omar Sultan Founder, President and Chief Executive Officer